# Ajanta Pharma Ltd. · 66-41 · INDIA — FDA import alert red lists: firms subject to detention without physical examination For Ajanta Pharma Ltd. · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Kamarga | Kamarga; product code is 65 P - - 02 Sildenafil Citrate (Regulator) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 01/20/2017; address is B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA, verified against its source on 2026-09-16. - **Firm:** Ajanta Pharma Ltd. _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** INDIA _(verified: appears in the quote below)_ - **Address:** B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA _(verified: appears in the quote below)_ - **Date published:** 01/20/2017 _(verified: appears in the quote below)_ - **Product code:** 65 P - - 02 Sildenafil Citrate (Regulator) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_ - **Product:** Kamarga | Kamarga _(verified: each item appears in the quote below)_ - **FDA notes:** Product contains Sildenafil Citrate | Product contains Sildenafil Citrate _(verified: each item appears in the quote below)_ ## What the source says > Ajanta Pharma Ltd. Date Published : 01/20/2017 B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA 65 P - - 02 Sildenafil Citrate (Regulator) Date Published: 01/20/2017 Desc: Kamarga Notes: Product contains Sildenafil Citrate 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 01/20/2017 Desc: Kamarga Notes: Product contains Sildenafil Citrate ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).